期刊文献+

清肺克霉汤联合酮康唑对重型肝炎并发肺部真菌感染的疗效观察 被引量:2

Effect of Qingfei Kemei Decoction Combined with Ketoconazole on Severe Hepatitis Patients with Pulmonary Fungi Infection
下载PDF
导出
摘要 目的:了解清肺克霉汤治疗重型肝炎(简称重肝)患者并发肺部真菌感染的疗效。方法:治疗组68例采用酮康唑加用清肺克霉汤治疗,对照组66例只采用酮康唑治疗。结果:治疗组治愈率为42.65%(29/68),总有效率79.41%(54/68);对照组治愈率为24.24%(16/66),总有效率57.58%(38/66)。治疗组明显优于对照组(P<0.05)。结论:重肝患者合并肺部真菌感染在抗真菌治疗的同时伍用中医药治疗可提高抗真菌药物的疗效。 Objective:To probe into the effect of Qingfei kemei decoction on severe hepatitis patients with pulmonary fungi infection.Methods:Severe hepatitis patients with pulmonary fungi infection were divided into treatment group and control group.The former was treated by Qingfei kemei decoction combined with ketoconazole;the latter was treated only by ketoconazole.Results:The curative rate of treatment group and control group was 42.65%(29/68)and 24.24%(16/66);effective rate was 79.41%(54/68)and 57.58%(38/66),respectively.The former was significantly higher than the latter(P0.05).Conclusion:Qingfei kemei decoction combined with ketoconazole can improve efficacy of severe hepatitis patients with pulmonary fungi infection.
出处 《辽宁中医药大学学报》 CAS 2011年第1期154-155,共2页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 重型肝炎 肺部真菌感染 清肺克霉汤 酮康唑 severe hepatitis pulmonary fungi infection Qingfei kemei decoction ketoconazole
  • 相关文献

参考文献11

二级参考文献51

  • 1骆抗先.HBsAg阴性的HBV感染.乙型肝炎基础与临床(第2版)[M].北京:人民卫生出版社,2001.327-342.
  • 2Javid G, Khan RA, Khan BA, et al. Short-course ceftriaxone therapy in spontaneous bacterial peritonitis[J]. Postgrad Med J, 1998, 74(876): 592-595.
  • 3Iber FL. Patients with cirrhosis and liver failure at risk for bacterial and fungai infection[J]. Am J Gastroenterol, 1999,94(8) : 2001-2003.
  • 4骆抗先.乙型肝炎基础与临床:第2版[M].北京:人民卫生出版社,2001.403.
  • 5吕增春 陈世平 等.医院感染和抗菌药物应用的流行病学调查[J].药物与临床,2000,15(3):29-29.
  • 6Nucci M, Colombo AL, Spector N, et al. Breakthrough candidemia in neutropenic patients. Clin Infect Dis, 1997, 24: 275-276.
  • 7Knaus WA, Wagner DP, Draper EA, et al. The APACHE Ⅲ prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest, 1991, 100: 1619-1636.
  • 8Rex JH, Sobel JD. Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis, 2001, 32: 1191-1200.
  • 9Edmond MB, Wallace SE, McClish DK, et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis, 1999, 29: 239-244.
  • 10Beck Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infection in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis, 1993, 167: 1247-1251.

共引文献14059

同被引文献11

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部